Mitogen activated protein kinases (MAPKs) have a docking groove that interacts with linear motifs in binding partners. To determine the structural basis of binding specificity between MAPKs and docking motifs, we quantitatively analyzed the ability of fifteen linear motifs from diverse MAPK partners to bind to c-Jun N-terminal kinase 1 (JNK1), p38α and extracellular signal-regulated kinase 2 (ERK2). Classical docking motifs mediated highly specific binding only to JNK1, and only motifs with a sequence pattern distinct from the classical MAPK binding docking motif consensus could differentiate between the topographically similar docking grooves of ERK and p38. We also solved the crystal structures for four MAPK-docking peptide complexes that represented JNK-specific, ERK-specific or ERK-and p38-selective binding modes. These structures revealed that the regions located in between consensus positions in the docking motifs showed conformational diversity. Although the consensus positions in the docking motifs served as anchor points that bound to common MAPK surface features and mostly contributed to docking in a non-discriminatory fashion, specificity was determined mainly by the conformation of the intervening region between the anchor points. These insights enabled us to successfully design peptides with tailored MAPK binding profiles by rationally changing the length and amino acid composition of docking motif regions located between anchor points. We present a coherent structural model underlying MAPK docking specificity that reveals how short linear motifs

The seven 14-3-3 isoforms are highly abundant human proteins encoded by similar yet distinct genes. 14-3-3 proteins recognize phosphorylated motifs within numerous human and viral proteins. Here, we analyze by X-ray crystallography, fluorescence polarization, mutagenesis and fusicoccin-mediated modulation the structural basis and druggability of 14-3-3 binding to four E6 oncoproteins of tumorigenic human papillomaviruses. 14-3-3 isoforms bind variant and mutated phospho-motifs of E6 and unrelated protein RSK1 with different affinities, albeit following an ordered affinity ranking with conserved relative KD ratios. Remarkably, 14-3-3 isoforms obey the same hierarchy when binding to most of their established targets, as supported by literature and a recent human complexome map. This knowledge allows predicting proportions of 14-3-3 isoforms engaged with phosphoproteins in various tissues. Notwithstanding their individual functions, cellular concentrations of 14-3-3 may be collectively adjusted to buffer the strongest phosphorylation outbursts, explaining their expression variations in different tissues and tumors.